Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 314

Results For "low"

3908 News Found

Evonik invests in US-based 3D screen printing technology firm Laxxon Medical
News | March 07, 2022

Evonik invests in US-based 3D screen printing technology firm Laxxon Medical

Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time


Bone Biologics enters into supply agreement with MTF Biologics for demineralized bone matrix
Biotech | March 07, 2022

Bone Biologics enters into supply agreement with MTF Biologics for demineralized bone matrix

This supply agreement provides material for the company’s planned 30-patient pilot study, and later for its planned U.S. pivotal study in spine fusion patients


Lupin signs Mary Kom for its Shakti campaign promoting heart health
Healthcare | March 07, 2022

Lupin signs Mary Kom for its Shakti campaign promoting heart health

The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women


NATCO launches first generic version of Revlimid in the US
Drug Approval | March 07, 2022

NATCO launches first generic version of Revlimid in the US

NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene


Aurobindo Pharma Foundation dedicates mini-lift irrigation scheme
Sustainability | March 06, 2022

Aurobindo Pharma Foundation dedicates mini-lift irrigation scheme

With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle


Datar Cancer Genetics partners with Kokilaben Hospital to offer advanced cancer tests
Healthcare | March 06, 2022

Datar Cancer Genetics partners with Kokilaben Hospital to offer advanced cancer tests

A simple blood test detects over 30 types of cancers


USFDA approves expanded use of Bristol Myers Opdivo
Drug Approval | March 06, 2022

USFDA approves expanded use of Bristol Myers Opdivo

The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer


Healthium collaborates with Abhinav Bindra to treat sports injuries
Healthcare | March 06, 2022

Healthium collaborates with Abhinav Bindra to treat sports injuries

According to an Injury Surveillance Report by NCA last year, 14.75 % of players sustained shoulder injuries, 13.11% of players sustained knee injuries and almost 74 % players suffer from career-threatening Anterior Cruciate Ligament (ACL) injuries in the 1st two years of return to sport


Johnson & Johnson Vision Care receives USFDA approval for drug-eluting contact lens
Drug Approval | March 06, 2022

Johnson & Johnson Vision Care receives USFDA approval for drug-eluting contact lens

Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category


Aquestive Therapeutics and Haisco Pharmaceutical partner for riluzole in China.
Biotech | March 06, 2022

Aquestive Therapeutics and Haisco Pharmaceutical partner for riluzole in China.

Around 85% of ALS patients suffer from a progressive loss of bulbar functionality